Osmotic nephrosis. A clinical and experimental investigation.
D000818:Animals; D003593:Cytoplasm; D003911:Dextrans / Q000009:adverse effects*; D006801:Humans; D006982:Hypertonic Solutions / Q000009:adverse effects; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007668:Kidney / Q000378:metabolism; D007684:Kidney Tubules / Q000473:pathology; D008353:Mannitol / Q000009:adverse effects*; D008680:Metaraminol / Q000009:adverse effects; D008970:Molecular Weight; D009401:Nephrosis / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D009995:Osmosis; D051381:Rats
D003911:Dextrans; D006982:Hypertonic Solutions; D008353:Mannitol; D008680:Metaraminol